nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000837	0.000837	CcSEcCtD
Tobramycin—Rash—Tamoxifen—pancreatic cancer	0.000836	0.000836	CcSEcCtD
Tobramycin—Dermatitis—Tamoxifen—pancreatic cancer	0.000836	0.000836	CcSEcCtD
Tobramycin—Vomiting—Erlotinib—pancreatic cancer	0.000834	0.000834	CcSEcCtD
Tobramycin—Dyspnoea—Irinotecan—pancreatic cancer	0.000834	0.000834	CcSEcCtD
Tobramycin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Tobramycin—Headache—Tamoxifen—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Tobramycin—Rash—Erlotinib—pancreatic cancer	0.000828	0.000828	CcSEcCtD
Tobramycin—Dermatitis—Erlotinib—pancreatic cancer	0.000827	0.000827	CcSEcCtD
Tobramycin—Angiopathy—Docetaxel—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Tobramycin—Dehydration—Epirubicin—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Tobramycin—Immune system disorder—Docetaxel—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Tobramycin—Headache—Erlotinib—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Tobramycin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Tobramycin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000817	0.000817	CcSEcCtD
Tobramycin—Asthenia—Sunitinib—pancreatic cancer	0.000815	0.000815	CcSEcCtD
Tobramycin—Dry skin—Epirubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Tobramycin—Decreased appetite—Irinotecan—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Tobramycin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000813	0.000813	CcSEcCtD
Tobramycin—Hypokalaemia—Epirubicin—pancreatic cancer	0.000808	0.000808	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000808	0.000808	CcSEcCtD
Tobramycin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Tobramycin—Pruritus—Sunitinib—pancreatic cancer	0.000804	0.000804	CcSEcCtD
Tobramycin—Pain—Irinotecan—pancreatic cancer	0.0008	0.0008	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.0008	0.0008	CcSEcCtD
Tobramycin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000799	0.000799	CcSEcCtD
Tobramycin—Erythema—Docetaxel—pancreatic cancer	0.000793	0.000793	CcSEcCtD
Tobramycin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000793	0.000793	CcSEcCtD
Tobramycin—Nausea—Tamoxifen—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Tobramycin—Muscular weakness—Epirubicin—pancreatic cancer	0.000783	0.000783	CcSEcCtD
Tobramycin—Pain—Gemcitabine—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Tobramycin—Nausea—Erlotinib—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Tobramycin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000779	0.000779	CcSEcCtD
Tobramycin—Diarrhoea—Sunitinib—pancreatic cancer	0.000777	0.000777	CcSEcCtD
Tobramycin—Dysgeusia—Docetaxel—pancreatic cancer	0.000776	0.000776	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Tobramycin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000771	0.000771	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00077	0.00077	CcSEcCtD
Tobramycin—Asthma—Epirubicin—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Back pain—Docetaxel—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Pain—Fluorouracil—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000765	0.000765	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—pancreatic cancer	0.000764	0.000764	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—pancreatic cancer	0.000753	0.000753	CcSEcCtD
Tobramycin—Dizziness—Sunitinib—pancreatic cancer	0.000751	0.000751	CcSEcCtD
Tobramycin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000751	0.000751	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Tobramycin—Abdominal pain—Irinotecan—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Body temperature increased—Irinotecan—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Tobramycin—Anaemia—Docetaxel—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Tobramycin—Vomiting—Sunitinib—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Tobramycin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000721	0.000721	CcSEcCtD
Tobramycin—Rash—Sunitinib—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Tobramycin—Dermatitis—Sunitinib—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Tobramycin—Urticaria—Fluorouracil—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Tobramycin—Headache—Sunitinib—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Tobramycin—Leukopenia—Docetaxel—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Tobramycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000709	0.000709	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—pancreatic cancer	0.000694	0.000694	CcSEcCtD
Tobramycin—Cough—Docetaxel—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Tobramycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00069	0.00069	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Tobramycin—Infestation—Epirubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Tobramycin—Nausea—Sunitinib—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—pancreatic cancer	0.000673	0.000673	CcSEcCtD
Tobramycin—Asthenia—Irinotecan—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—pancreatic cancer	0.000667	0.000667	CcSEcCtD
Tobramycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Tobramycin—Asthenia—Gemcitabine—pancreatic cancer	0.000654	0.000654	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—pancreatic cancer	0.000652	0.000652	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Tobramycin—Pruritus—Gemcitabine—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Tobramycin—Diarrhoea—Irinotecan—pancreatic cancer	0.00064	0.00064	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Tobramycin—Pruritus—Fluorouracil—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—pancreatic cancer	0.000628	0.000628	CcSEcCtD
Tobramycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000624	0.000624	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000621	0.000621	CcSEcCtD
Tobramycin—Dizziness—Irinotecan—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Tobramycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—pancreatic cancer	0.000602	0.000602	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—pancreatic cancer	0.000597	0.000597	CcSEcCtD
Tobramycin—Vomiting—Irinotecan—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—pancreatic cancer	0.000594	0.000594	CcSEcCtD
Tobramycin—Dizziness—Fluorouracil—pancreatic cancer	0.000593	0.000593	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—pancreatic cancer	0.000592	0.000592	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Tobramycin—Rash—Irinotecan—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Tobramycin—Dermatitis—Irinotecan—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Tobramycin—Headache—Irinotecan—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—pancreatic cancer	0.000581	0.000581	CcSEcCtD
Tobramycin—Vomiting—Gemcitabine—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Tobramycin—Rash—Gemcitabine—pancreatic cancer	0.000575	0.000575	CcSEcCtD
Tobramycin—Dermatitis—Gemcitabine—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Tobramycin—Headache—Gemcitabine—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Tobramycin—Vomiting—Fluorouracil—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Tobramycin—Rash—Fluorouracil—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Tobramycin—Dermatitis—Fluorouracil—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Tobramycin—Headache—Fluorouracil—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Tobramycin—Nausea—Irinotecan—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Tobramycin—Pain—Docetaxel—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Tobramycin—Nausea—Gemcitabine—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Tobramycin—Erythema—Epirubicin—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Tobramycin—Nausea—Fluorouracil—pancreatic cancer	0.000532	0.000532	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—pancreatic cancer	0.000531	0.000531	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—pancreatic cancer	0.000524	0.000524	CcSEcCtD
Tobramycin—Back pain—Epirubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—pancreatic cancer	0.000504	0.000504	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000496	0.000496	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—pancreatic cancer	0.000495	0.000495	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—pancreatic cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Malaise—Epirubicin—pancreatic cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000477	0.000477	CcSEcCtD
Tobramycin—Cough—Epirubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—pancreatic cancer	0.000466	0.000466	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000459	0.000459	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—pancreatic cancer	0.000446	0.000446	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—pancreatic cancer	0.000444	0.000444	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000436	0.000436	CcSEcCtD
Tobramycin—Cough—Doxorubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—pancreatic cancer	0.000411	0.000411	CcSEcCtD
Tobramycin—Rash—Docetaxel—pancreatic cancer	0.000408	0.000408	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—pancreatic cancer	0.000408	0.000408	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Tobramycin—Headache—Docetaxel—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000404	0.000404	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000396	0.000396	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—pancreatic cancer	0.000392	0.000392	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—pancreatic cancer	0.000392	0.000392	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Tobramycin—Nausea—Docetaxel—pancreatic cancer	0.000384	0.000384	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—pancreatic cancer	0.000379	0.000379	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Tobramycin—Pain—Epirubicin—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000368	0.000368	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000357	0.000357	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000351	0.000351	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—pancreatic cancer	0.000347	0.000347	CcSEcCtD
Tobramycin—Pain—Doxorubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00033	0.00033	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000322	0.000322	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—pancreatic cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—pancreatic cancer	0.000299	0.000299	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—pancreatic cancer	0.00029	0.00029	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—pancreatic cancer	0.000289	0.000289	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—pancreatic cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—pancreatic cancer	0.000277	0.000277	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000276	0.000276	CcSEcCtD
Tobramycin—Rash—Epirubicin—pancreatic cancer	0.000275	0.000275	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—pancreatic cancer	0.000275	0.000275	CcSEcCtD
Tobramycin—Headache—Epirubicin—pancreatic cancer	0.000273	0.000273	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—pancreatic cancer	0.000267	0.000267	CcSEcCtD
Tobramycin—Nausea—Epirubicin—pancreatic cancer	0.000259	0.000259	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—pancreatic cancer	0.000257	0.000257	CcSEcCtD
Tobramycin—Rash—Doxorubicin—pancreatic cancer	0.000255	0.000255	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—pancreatic cancer	0.000254	0.000254	CcSEcCtD
Tobramycin—Headache—Doxorubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—pancreatic cancer	0.00024	0.00024	CcSEcCtD
